{
    "nct_id": "NCT03929783",
    "official_title": "Improving PPV3 Using Contrast Enhanced Mammography (CEM) in Diagnostic Assessment by Reducing Benign Tissue Diagnosis (FP3) - A Single-Arm Prospective Study",
    "inclusion_criteria": "* Women with digital breast tomosynthesis and/or ultrasound assessments of Breast Imaging Reporting and Data System (BI-RADS) 4 and 5 lesions with recommendation of needle biopsy for tissue diagnosis.\n* Abnormal findings include masses, focal, global or developing asymmetries, architecture distortions, or > 1 cm of suspicious calcifications with or without associated ultrasound abnormal findings.\n* Scheduled for imaging guided percutaneous needle biopsy.\n* Provide signed and dated informed consent form.\n* If patient is of childbearing potential, a negative pregnancy test, urine or blood, within 14 days prior to the scan.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 30 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* < 1 cm span of calcifications without an ultrasound correlate.\n* Pregnant patients.\n* Patients with known allergy to iodinated contrast material.\n* If patient answers YES to any of the below questions they need glomerular filtration rate (gFR) prior to contrast administration regardless of their age:\n\n  * Have you ever been told you have renal problems?\n  * Have you ever been told you have protein in your urine?\n  * Do you have high blood pressure?\n  * Do you have diabetes?\n  * Do you have gout?\n  * Have you ever had kidney surgery?",
    "miscellaneous_criteria": ""
}